EN
HI
Summary
As of 14 Nov, 2026, Alkem Laboratories stock price is ₹4644.5. During the trading session, the stock has moved between an intraday low of ₹4644.00 and an intraday high of ₹5620.00. Over the last 52 weeks, Alkem Laboratories has traded between ₹4644.00 and ₹5933.50.
The stock has recorded a trading volume of 1,08,133 shares,. Its Average Traded Price (ATP) is ₹5187.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹4644.50.
Alkem Laboratories has an upper circuit limit of ₹5832.00 and a lower circuit limit of ₹4772.00. The total value traded stands at ₹56.09 CR, and the delivery percentage for the day is 26.66%.
The stock is currently traded with a market lot size of 1. Alkem Laboratories also offers a dividend yield of 0.99%.
Alkem Laboratories Share Price Chart
Alkem Laboratories Share Key Metrics
Volume
1.08 L
Market Cap
61145.54 CR
LTQ@LTP
2@4644.50
ATP
5187.1
Var Margin
12.5 %
Circuit Range
4772-5832
Delivery %
26.66 %
Value
56.09 CR
ASM/GSM
No
Market Lot
1
Alkem Laboratories Fundamentals
P/E Ratio
30.85
P/B Ratio
4.46
Div. Yield
0.99
Sector P/E
41.35
Sector P/B
3.85
Sec. Div. Yield
0.53
Alkem Laboratories Resistance and Support
Pivot 5299
Resistance
First Resistance
5425
Second Resistance
5548
Third Resistance
5674
Support
First Support
5176
Second Support
5050
Third Support
4927
Alkem Laboratories Futures & Options
Alkem Laboratories Option Chain
View Price, OI, Greeks & More...
23NOV26
5166.00
-161.00 (3.02%)
29DEC26
5191.50
-156.50 (2.93%)
25JAN27
5208.00
-167.50 (3.12%)
ALKEM|23NOV26 CE 5100.00
161.80
-114.4 (-41.42%)
ALKEM|23NOV26 PE 5150.00
98.3
33.45 (51.58%)
Alkem Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 5300 | 5114 | -3.55% | 5300.5 | 5103.5 |
| Thu Nov 12 2026 | 5422 | 5302 | -2.68% | 5422 | 5173 |
| Wed Nov 11 2026 | 5400 | 5448 | 0.92% | 5448 | 5277 |
Alkem Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-12 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Interim Dividend |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Alkem Laboratories News
Alkem Laboratories Ltd - 539523 - Announcement Under Reg 30 - Investor Presentation
Alkem Laboratories reported Q2 FY27 revenue of Rs.4,552 crores (up 13.8% YoY) and net profit of Rs.675.3 crores (down 11.7% YoY). The company announced the appointment of Dr. Amrut Naik as Chief Executive Officer and noted a successful USFDA inspection at its Mandva API plant with zero observations.
Nov 12 2026 13:58:27
Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 12/11/2026
Alkem Laboratories reported Q2 FY27 cons. revenue of ₹4,552.0 crores (up 13.8% YoY) and net profit of ₹667.1 crores (down 14.4% YoY). The results feature an exceptional recovery of ₹35.0 crores from a prior investment and reflect the recent consolidation of a 55% stake acquired in Occlutech Holding AG.
Nov 12 2026 13:50:30
Read More
Alkem Laboratories Management
| Name | Position |
|---|---|
| Neela Bhattacherjee | Non Executive Independent Director |
| Manish Narang | President – Legal, Company Secretary & Compliance Officer |
Alkem Laboratories Similar Stocks
Aurobindo Pharma Ltd.
1777.10
-30.10 (1.67%)
Lupin Ltd.
2035.00
20.00 (0.99%)
Max Healthcare Institute Ltd.
967.00
20.70 (2.19%)
Manipal Health Enterprises Ltd.
597.00
-79.50 (11.75%)
Glenmark Pharmaceuticals Ltd.
2696.00
36.20 (1.36%)
Aster DM Quality Care Ltd.
673.35
-62.55 (8.50%)
Biocon Ltd.
375.00
4.05 (1.09%)
Fortis Healthcare Ltd.
767.00
7.00 (0.92%)
Abbott India Ltd.
25495.00
-1105.00 (4.15%)
Anthem Biosciences Ltd.
1074.00
135.55 (14.44%)
Alkem Laboratories FAQs
The Buying Price of Alkem Laboratories share is 4644.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alkem Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alkem Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alkem Laboratories shares is 30.85. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alkem Laboratories shares is 4.46. Useful to assess the stock's value relative to its book value.
To assess Alkem Laboratories’s valuation compare Sector P/E, P/B which are 41.35 & 3.85 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alkem Laboratories is 61145.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alkem Laboratories share price is 5933.50 & 4644.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alkem Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ALKEM
